Enfamil NeuroPro Study
Launched by UNIVERSITY OF ARIZONA · Sep 22, 2023
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
The Enfamil NeuroPro Study is looking at how different types of infant feeding affect the bacteria in babies’ guts, which can play a role in their development. The study will compare three groups of infants: those who are fed a standard infant formula called Enfamil Infant, those who are fed a new formula designed to be closer to breast milk called Enfamil NeuroPro, and those who are breastfed. All of these formulas are safe and meet the requirements set by the FDA.
To participate in this study, infants must be healthy, full-term babies and their parents need to agree to take part. Parents should have a smartphone and be willing to answer weekly online questions about their baby’s feeding. However, babies who were born prematurely, through a C-section, have health issues, or are receiving both breast milk and formula are not eligible. If you decide to join, you will help researchers learn more about how different feeding methods can impact infant gut health and overall development.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy term infants with parental consent
- • Parents are able to provide informed consent; own a smart phone and are able to fill out weekly digital questionnaires.
- Exclusion Criteria:
- • Prematurity (\<= 36 weeks gestational age)
- • Babies born through c-section
- • Any health issues identified at the first postpartum screening
- • Use of both breast milk and formula
- • Use of donor breast milk
- • Parent unwillingness/inability to avoid giving prebiotics, probiotics, symbiotics, and immune-stimulating products to the child for the duration of this study
About University Of Arizona
The University of Arizona is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources and expertise to explore new therapeutic approaches and enhance patient outcomes. Committed to ethical research practices and community engagement, the University of Arizona fosters an environment that promotes scientific discovery and the translation of research findings into clinical applications. Its clinical trial initiatives encompass a wide range of medical disciplines, reflecting the institution's mission to improve health and well-being locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tucson, Arizona, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported